Publications by authors named "Jason D Downey"

Claim this Profile
T
The effect of the EP3 antagonist DG-041 on male mice with diet-induced obesity.
Ryan P Ceddia, Jason D Downey, Ryan D Morrison, Maria P Kraemer, Sarah E Davis

Prostaglandins Other Lipid Mediat· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DMTS is an effective treatment in both inhalation and injection models for cyanide poisoning using unanesthetized mice.
Susan M DeLeon, Jason D Downey, Diane M Hildenberger, Melissa O Rhoomes, Lamont Booker

Clin Toxicol (Phila)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere.
Jason D Downey, Sam A Saleh, Thomas M Bridges, Ryan D Morrison, J Scott Daniels

Bioorg Med Chem Lett· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for the presence of a critical disulfide bond in the mouse EP3γ receptor.
Jason D Downey, Charles R Sanders, Richard M Breyer

Prostaglandins Other Lipid Mediat· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PGE2 decreases reactivity of human platelets by activating EP2 and EP4.
James P Smith, Elias V Haddad, Jason D Downey, Richard M Breyer, Olivier Boutaud

Thromb Res· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis